Medfinder
Expert medication guides

The Found Script

Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.

4080 articles in Drug ShortagesClear all filters
Why Is Alavert D XR So Hard to Find? [Explained for 2026]
Drug Shortages

Why Is Alavert D XR So Hard to Find? [Explained for 2026]

Can't find Alavert D XR at your pharmacy? Learn why this allergy and congestion medication is hard to find in 2026 and what you can do about it.

By Peter Daggett·
Abiraterone Shortage Update: What Patients Need to Know in 2026
Drug Shortages

Abiraterone Shortage Update: What Patients Need to Know in 2026

Is Abiraterone in shortage in 2026? Get the latest update on availability, pricing, and what prostate cancer patients can do to stay on treatment.

By Peter Daggett·
Tobramycin Shortage: What Providers and Prescribers Need to Know in 2026
For Healthcare ProvidersDrug Shortages

Tobramycin Shortage: What Providers and Prescribers Need to Know in 2026

A provider-focused briefing on the 2026 Tobramycin shortage. Covers supply timeline, prescribing implications, alternatives, and tools for your practice.

By Peter Daggett·
Why Is Cequa So Hard to Find? [Explained for 2026]
Drug Shortages

Why Is Cequa So Hard to Find? [Explained for 2026]

Having trouble finding Cequa at your pharmacy? Learn why this dry eye medication can be hard to find in 2026 and what you can do to get your prescription filled.

By Peter Daggett·

37,000+ have already found their meds with Medfinder.

Stop calling pharmacies. Start your search today.

Hyperrho Shortage Update: What Patients Need to Know in 2026
Drug Shortages

Hyperrho Shortage Update: What Patients Need to Know in 2026

Is Hyperrho still in shortage in 2026? Get the latest update on availability, pricing, alternatives, and how to find Rho(D) immune globulin.

By Peter Daggett·
Medrol shortage update: What patients need to know in 2026
Drug Shortages

Medrol shortage update: What patients need to know in 2026

Get the latest Medrol shortage update for 2026. Learn what's causing the Methylprednisolone supply issues and how to get your prescription filled.

By Peter Daggett·
Trokendi XR Shortage: What Providers and Prescribers Need to Know in 2026
For Healthcare ProvidersDrug Shortages

Trokendi XR Shortage: What Providers and Prescribers Need to Know in 2026

A clinical briefing for providers on Trokendi XR availability in 2026. Understand the supply landscape, prescribing implications, and tools to help patients.

By Peter Daggett·
Locoid Shortage Update: What Patients Need to Know in 2026
Drug Shortages

Locoid Shortage Update: What Patients Need to Know in 2026

Get the latest Locoid shortage update for 2026. Learn what's causing supply issues, what it costs, and how to find Hydrocortisone Butyrate in stock.

By Peter Daggett·
Baclofen Shortage: What Providers and Prescribers Need to Know in 2026
For Healthcare ProvidersDrug Shortages

Baclofen Shortage: What Providers and Prescribers Need to Know in 2026

A clinical briefing on the Baclofen shortage for providers. Covers the shortage timeline, prescribing implications, alternatives, cost, and tools to help patients.

By Peter Daggett·
Why Is Ramelteon So Hard to Find? [Explained for 2026]
Drug Shortages

Why Is Ramelteon So Hard to Find? [Explained for 2026]

Having trouble finding Ramelteon (Rozerem) at your pharmacy? Learn why this sleep medication can be hard to find and what you can do about it in 2026.

By Peter Daggett·
Why Is CombiPatch So Hard to Find? [Explained for 2026]
Drug Shortages

Why Is CombiPatch So Hard to Find? [Explained for 2026]

CombiPatch is hard to find in 2026 due to ongoing shortages, manufacturing issues, and rising HRT demand. Learn why and what you can do about it.

By Peter Daggett·
Xifaxan Shortage: What Providers and Prescribers Need to Know in 2026
For Healthcare ProvidersDrug Shortages

Xifaxan Shortage: What Providers and Prescribers Need to Know in 2026

A clinical briefing on Xifaxan availability in 2026. Covers supply status, prescribing implications, cost barriers, alternatives, and tools for providers.

By Peter Daggett·
PreviousPage 105 of 340Next